Dr. ERIC FEIGL-DING is an epidemiologist, nutritionist, health economist, and faculty at the Harvard Chan School of Public Health, and Chief Health Economist for the non-profit Microclinic International. He is a Soros Fellow, founder of Happy Vitals, and founder of the 6-million member Campaign for Cancer Prevention.
His academic work focuses on the intersection of public health, nutrition, and health economics -- with expertise in big data, randomized trials, technology, maternal and child health, and virality of social networks. He has published in leading journals, including the New England Journal of Medicine, Journal of the American Medical Association, The Lancet, and Health Policy. His 100+ publications have received 13,000 external citations (H-Index 39). He is Principal Investigator of several randomized trials of social network interventions for obesity and diabetes in the U.S. and abroad in Jordan, Qatar, and Denmark. Altogether, his competitively awarded projects as PI/CEO/Director have been funded with over $10 million in funding.
A Google Tech Talk keynote speaker, a World Economic Forum Global Shaper, he has worked with the World Health Organization, European Commission, and was a judge for the VH1 Do Something Awards, judge for the Soros Fellowship, and member of the Global Burden of Disease Project and US Disease Burden Collaboration.
A cancer prevention advocate and childhood tumor survivor, he founded the 6 million member online Campaign for Cancer Prevention, with Causes, and featured in Newsweek. In total online reach, he directed several health and disease prevention advocacy platforms, with 17 million members. He led the first ever direct-to-science online crowdfunding initiative, raising over $500,000 for medical research on Causes on Facebook, and featured in the New York Times.
In 2006, he was noted for his role as a whistleblower and leading a key two-year-long investigation into the controversial drug safety and risk data of Vioxx®, Celebrex®, and Bextra® that drew FDA and national attention. Highlighted and express-published in JAMA, as chief corresponding author, he was recognized in the New York Times.
Recognized for his data innovations at a Google Tech Talk, he led a 'Moneyball' study of Major League Baseball players across 130-years and over 500,000+ MLB player-years of data, which highlighted the mortality risks of obesity and body size in athletes, especially in high BMI home-run hitters.
He is also the inventor of several scientific innovations: the Lipophilic Index and Lipophilic Load for fatty acids, meta-regression Spaghetti Plot analysis of non-linear splines, the Evidenced Formal Coverage Index for healthcare coverage, and the Isotemporal Substitution risk model for time displacement causation.
He was awarded the 2014 Global Health Project of the Year by the Consortium of Universities for Global Health, awarded the 2012 Outstanding Young Leader Award from the Boston Chamber of Commerce, awarded the 2015 American Heart Association Scott Grundy Excellence Award, named among Craig Newmark’s “16 People and Organizations Changing the World in 2012”, and his work recognized as ‘Best of the American Heart Association’, thrice, in 2013, 2014, 2015.
He has been featured in the Chronicle of Philanthropy, Newsweek, The New York Times, Boston Globe, Glamour, among two dozen newspapers/magazines, and profiled in several books including: CauseWired (Tom Watson 2008), Zilch (Nancy Lublin 2010), Shift & Reset (Brian Reich 2011), and Thinfluence (Walter Willett 2014). He was also awarded the Paul and Daisy Soros Fellowship in 2008.
He attended The Johns Hopkins University, graduating with Honors in Public Health and Phi Beta Kappa (junior year election) at age 21. He completed his dual doctorate in epidemiology and doctorate in nutrition at age 23 from Harvard University. He also completed his post-doctoral fellowship at the Harvard School of Public Health. Teaching at Harvard over 12 years, he has lectured in more than a dozen graduate and undergraduate courses, for which he received the Derek Bok Distinction in Teaching Award from Harvard College.